Etomidate vs. Midazolam for Sedation During ERCP

PHASE4CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
CholedocholithiasisCholangiocarcinomaPancreatitisPancreatic Cancer
Interventions
DRUG

Etomidate

This cohort would be administered etomidate with meperidine. The initial dose of etomidate is 0.1mg/kg IV and meperidine, 25mg. Additional dose of etomidate is 2mg(1cc). In old age cased, more than 65 years old, 30% of initial dose discounted.

DRUG

Midazolam

This cohort would be administered midazolam with meperidine. The initial dose of midazolam is 0.06mg/kg IV and meperidine 50mg IV. Additional dose is 1mg of midazolam. In the elders, more than 65 years old, initial dose was declined to 70%.

DRUG

Meperidine

Both groups were administered same dose of meperidinie 50mg. Then elders \> 80 years old were administered 25mg iv bolus.

Trial Locations (1)

690-766

1Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital, Jeju City

All Listed Sponsors
lead

Cheju Halla General Hospital

OTHER

NCT02027311 - Etomidate vs. Midazolam for Sedation During ERCP | Biotech Hunter | Biotech Hunter